查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1520554

2024-2032 年智慧吸入器市場報告（按產品、適應症（氣喘、慢性阻塞性肺病）、配銷通路和地區）

Smart Inhalers Market Report by Product, Indication (Asthma, Chronic Obstructive Pulmonary Disease ), Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球智慧吸入器市場規模達到2.525億美元。

智慧型吸入器是一種呼吸吸入器，可監控依從性、發送劑量提醒、透過藍牙存取易於共享的訊息，並準確記錄每次給藥的時間、日期和位置。它們還可以幫助提高治療依從性，增加患者控制症狀的參與度和積極性，並提供可能影響胸部的環境和天氣條件的報告。由於氣喘和慢性阻塞性肺病（COPD）的盛行率不斷上升，全球對智慧吸入器的需求不斷增加。

智慧吸入器市場趨勢：

由於全球空氣污染水平上升，慢性呼吸道疾病（CRD）、肺癌、慢性支氣管炎和急性下呼吸道感染（ALRI）患者數量顯著增加。這是推動市場成長的關鍵因素之一。此外，不正確的吸入器技術和依從性差可能會對傳統吸入器的功效產生負面影響，這可能導致患者病情惡化。然而，智慧吸入器可以使用旨在與行動應用程式連接以監控用藥時間表和後續劑量的數位功能來解決患者和醫療保健專業人員在管理這些疾病方面的挑戰。此外，當症狀需要採取特定行動時，它們可以提醒患者和臨床醫生，並促進轉向更好的自我照護。再加上智慧吸入器技術的最新進展，可以向用戶反饋其吸入器技術併計算正確的依從性水平，正在推動市場發展。除此之外，患者對使用智慧吸入器好處的認知不斷增強，預計將提高整體銷售額和獲利能力。

本報告回答的關鍵問題

  • 2023年全球智慧吸入器市場規模有多大？
  • 2024-2032年全球智慧吸入器市場的預期成長率是多少？
  • COVID-19 對全球智慧吸入器市場有何影響？
  • 推動全球智慧吸入器市場的關鍵因素是什麼？
  • 基於產品的全球智慧吸入器市場的詳細情形如何？
  • 根據該指標，全球智慧吸入器市場的細分如何？
  • 基於配銷通路的全球智慧吸入器市場的詳細情形如何？
  • 全球智慧吸入器市場的重點區域有哪些？
  • 全球智慧吸入器市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球智慧吸入器市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 吸入器
    • 市場走向
    • 關鍵環節
      • 乾粉吸入器
      • 定量吸入器
    • 市場預測
  • 霧化器
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依跡象

  • 氣喘
    • 市場走向
    • 市場預測
  • 慢性阻塞性肺病（COPD）
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路商店
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • Adherium Limited
    • AptarGroup Inc.
    • AstraZeneca plc
    • Boehringer Ingelheim
    • Cognita Labs
    • GlaxoSmithKline plc
    • Novartis AG
    • OPKO Health Inc.
    • Propeller Health (ResMed)
    • Sensirion AG
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group Limited (Philip Morris International Inc.)
Product Code: SR112024A5417

The global smart inhalers market size reached US$ 252.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,370.6 Million by 2032, exhibiting a growth rate (CAGR) of 20.3% during 2024-2032.

Smart inhalers are respiratory inhalers that can monitor adherence, send dosage reminders, offer access to readily shareable information via Bluetooth, and record the time, date and location of each dosage administered accurately. They can also help improve compliance with therapy, increase patient involvement and motivation in controlling symptoms, and provide reports about environmental and weather conditions that may affect their chest. Due to the growing prevalence of asthma and chronic obstructive pulmonary diseases (COPD), there is a rise in the demand for smart inhalers across the globe.

Smart Inhalers Market Trends:

Due to a rise in air pollution levels worldwide, there is a significant increase in the number of patients with chronic respiratory diseases (CRDs), lung cancer, chronic bronchitis, and acute lower respiratory infections (ALRI). This represents one of the key factors propelling the growth of the market. Moreover, the efficacy of conventional inhalers can be negatively impacted by incorrect inhaler techniques and poor adherence, which may result in the progression of patients' condition. However, smart inhalers can address the challenges of patients and healthcare professionals in the management of these diseases using digital features designed to connect with mobile applications for monitoring medication schedules and subsequent dosing. Additionally, they can alert patients and clinicians when symptoms require specific action and facilitate a shift to better self-care. This, coupled with recent advances in smart inhaler technology, which allow feedback to users on their inhaler technique and the calculation of the correct level of adherence, is driving the market. Besides this, the increasing awareness about the benefits of using smart inhalers among patients is projected to augment the overall sales and profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global smart inhalers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

Inhalers

Dry Powdered Inhaler

Metered Dose Inhaler

Nebulizers

Breakup by Indication:

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Adherium Limited, AptarGroup Inc., AstraZeneca plc, Boehringer Ingelheim, Cognita Labs, GlaxoSmithKline plc, Novartis AG, OPKO Health Inc., Propeller Health (ResMed), Sensirion AG, Teva Pharmaceutical Industries Ltd. and Vectura Group Limited (Philip Morris International Inc.).

Key Questions Answered in This Report

  • 1. What was the size of the global smart inhalers market in 2023?
  • 2. What is the expected growth rate of the global smart inhalers market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global smart inhalers market?
  • 4. What are the key factors driving the global smart inhalers market?
  • 5. What is the breakup of the global smart inhalers market based on the product?
  • 6. What is the breakup of the global smart inhalers market based on the indication?
  • 7. What is the breakup of the global smart inhalers market based on distribution channel?
  • 8. What are the key regions in the global smart inhalers market?
  • 9. Who are the key players/companies in the global smart inhalers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Smart Inhalers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Dry Powdered Inhaler
      • 6.1.2.2 Metered Dose Inhaler
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Adherium Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AptarGroup Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 AstraZeneca plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boehringer Ingelheim
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Cognita Labs
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 GlaxoSmithKline plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 OPKO Health Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Propeller Health (ResMed)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sensirion AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Teva Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Vectura Group Limited (Philip Morris International Inc.)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Smart Inhalers Market: Major Drivers and Challenges
  • Figure 2: Global: Smart Inhalers Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Smart Inhalers Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Smart Inhalers Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Smart Inhalers Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Smart Inhalers Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Smart Inhalers (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Smart Inhalers (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Smart Inhalers (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Smart Inhalers (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Smart Inhalers (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Smart Inhalers (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Smart Inhalers (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Smart Inhalers (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Smart Inhalers (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Smart Inhalers (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Smart Inhalers (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Smart Inhalers (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Smart Inhalers (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Smart Inhalers (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Smart Inhalers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Smart Inhalers Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: Smart Inhalers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Smart Inhalers Industry: SWOT Analysis
  • Figure 72: Global: Smart Inhalers Industry: Value Chain Analysis
  • Figure 73: Global: Smart Inhalers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Smart Inhalers Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Smart Inhalers Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Smart Inhalers Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Smart Inhalers Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Smart Inhalers Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Smart Inhalers Market: Competitive Structure
  • Table 7: Global: Smart Inhalers Market: Key Players